Clinical Trial Update: Mechanistic Study of the Systolic Blood Pressure Lowering Effect of Dapagliflozin in Type 2 Diabetes [Phase 4]

View source ↗

Summary

This is a Phase 4 mechanistic clinical trial update assessing how dapagliflozin lowers systolic blood pressure in adults with type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: Gulf Regional Research & Educational Services, LLC | Conditions: Diabetes Mellitus Type 2 | Phase 4 | Status: UNKNOWN